Literature DB >> 7462689

Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen.

D L Kasper, A B Onderdonk, B G Reinap, A A Linberg.   

Abstract

The amount of capsular antigen produced by Bacteroides fragilis appears to decrease significantly with in vitro passage on blood agar plates of strain 23745. This decrease in the quantity of isolable capsule is associated with the emergence of a small transparent colony type variant. The small colony type strain also has a glycogenlike material associated with its outer membrane. This glycogen is found intracellularly but is not associated with the outer membrane on the mucoid colony variant that predominates after passage in animals--the large colony type. No concomitant alteration in outer membrane proteins or lipopolysaccharides is associated with this colonial transformation. Electron micrographs, with either ruthenium red staining or indirect ferritin antibody staining of the capsular antigen, confirm the relative loss of capsule with in vitro passage. Thus, care must be taken during in vitro studies of the antigenic structure of B. fragilis to define the degree of passage of the strain.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7462689     DOI: 10.1093/infdis/142.5.750

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis.

Authors:  A Pantosti; A O Tzianabos; A B Onderdonk; D L Kasper
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Capsular material of Mycoplasma gallisepticum and its possible relevance to the pathogenic process.

Authors:  M Tajima; T Yagihashi; Y Miki
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

3.  Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain.

Authors:  W M Kalka-Moll; Y Wang; L E Comstock; S E Gonzalez; A O Tzianabos; D L Kasper
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera.

Authors:  A S Kreger; L D Gray; J Testa
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

5.  Characterization of opsonins for Bacteroides fragilis in immune sera collected from experimentally infected mice.

Authors:  T M Ellis; J T Barrett
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Lipopolysaccharides from Bacteroides fragilis are mitogenic for spleen cells from endotoxin responder and nonresponder mice.

Authors:  K A Joiner; K P McAdam; D L Kasper
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

7.  Bactericidal activity of a granule extract from human polymorphonuclear leukocytes against Bacteroides species.

Authors:  H Pruul; B L Wetherall; P J McDonald
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

8.  Chemical and immunochemical analyses of Bacteroides fragilis lipopolysaccharides.

Authors:  A Weintraub; B E Larsson; A A Lindberg
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

9.  Polymorphonuclear neutrophil chemotaxis induced and inhibited by Bacteroides spp.

Authors:  S A Adamu; J F Sperry
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

10.  Effect of anaerobic bacteria on killing of Proteus mirabilis by human polymorphonuclear leukocytes.

Authors:  F Namavar; A M Verweij; M Bal; T J van Steenbergen; J de Graaff; D M MacLaren
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.